Allergan & Darden cases highlight missing shareholder protections in the US

The Listing Rules of the UK Listing Authority have for many years included a requirement for shareholder approval of significant transactions. Whether or not a transaction is considered “significant” is set out in the Class Tests, defined in the Listing Rules.… Read the rest

UK Governance Code Moves On

After what has probably been the most exhausting proxy season for investors and issuers alike, the regulatory momentum shows no sign of easing. The new UK Corporate Governance Code goes live for all companies reporting to shareholders on or after 1 October 2014.… Read the rest